0
Obstructive Lung Diseases |

Effect of the Breathe Noninvasive Open Ventilation (NIOV) Device on Breathing Pattern of Patients with Severe COPD

Viola Tracy, MD; Matthew Cohn, MD; Aarti Grover, MD; Rebecca Mabry, MD; Nicholas Hill, MD
Author and Funding Information

Tufts Medical Center, Boston, MA


Chest. 2013;144(4_MeetingAbstracts):743A. doi:10.1378/chest.1705214
Text Size: A A A
Published online

Abstract

SESSION TITLE: Dyspnea in COPD

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Sunday, October 27, 2013 at 04:15 PM - 05:15 PM

PURPOSE: The NIOV respiratory assist device (Breathe Technologies, Inc) uses novel technology to generate nasal gas flow to augment ventilation. Using compressed air or oxygen, the NIOV uses specially designed loose fitting nasal prongs to generate augmented airflow using the Bernoulli principle. We sought to determine the effect of different NIOV settings on diaphragm function and breathing pattern.

METHODS: The NIOV device was connected to a 50 psi oxygen source and set at one of 3 different settings to provide more or less respiratory assistance administered in random fashion. Patients with severe COPD (GOLD stage 3 or 4) who were using accessory muscles at rest were offered enrollment. Consenting patients were studied sitting during the daytime. Tidal volume was measured using impedance plethysmography, oxygenation saturation and Ptc(transcutaneous)CO2 using a Sentec monitor, and esophageal, gastric and transdiaphragmatic pressures using manometry balloons. Continuous positive airway pressure (PAP) and Bilevel PAP (BPAP) were used for comparison.

RESULTS: Five patients have been studied thus far, with age 62 years, body mass index 24.7 m/kg2, FEV1 1.3L and FEV1% 32.8. Mean responses and SEMs are as follows (n = 5 for Breathe, n = 2 for CPAP, BiPAP): Mean values VT (mL) Esoph TDP ΔP RR PtcCO2 Baseline/mask 472±60 11.0±2.3 12.7±2.2 16.6±1.6 40.0±0.7 Breathe 100 488±125 10.2±2.4 14.5±2.4 15.2±1.9 38.7±1.4 Breathe 180 507±115 10.0±2.4 13.8±2.4 14.8±1.9 38.6±1.5 Breathe 250 587±141* 10.4±1.8 14.2±1.5 14.6±2.4 36.6±1.3* CPAP 4 557 9.3 12.1 17 39.2 BPAP 8/4 656 6.7 8.4 18 37.5 BPAP 12/4 840 4.4 9.4 11 36.3

CONCLUSIONS: The NIOV device significantly enhances tidal volume and lowers PtcCO2 in patients with severe COPD without significantly lowering esophageal or trans-diaphragmatic pressure, consistent with improved ventilatory efficiency. BPAP appears to achieve both of these effects and also lowers esophageal pressure swings.

CLINICAL IMPLICATIONS: The Breathe NIOV improves ventilator efficiency in patients with severe COPD and may be of use in alleviating dyspnea or enhancing exercise capacity.

DISCLOSURE: Rebecca Mabry: Employee: Breathe Technologies The following authors have nothing to disclose: Viola Tracy, Matthew Cohn, Aarti Grover, Nicholas Hill

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543